Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype
about
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineApolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysisThe crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemiaSugar consumption, metabolic disease and obesity: The state of the controversyWhy Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.Loss-of-function mutations in APOC3, triglycerides, and coronary diseaseStatins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesionTreatment options for hypertriglyceridemia: from risk reduction to pancreatitis.Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases.Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.Complexities of plasma apolipoprotein C-III metabolismObesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart diseaseThe effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidismInvestigations of apoC-III metabolism using stable isotopes: what information can you acquire and how can you interpret your results?Individual differences in hyperlipidemia and vitamin E status in response to chronic alcohol self-administration in cynomolgus monkeysTriglycerides and heart disease: still a hypothesis?Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.Lack of association between apolipoprotein C3 gene polymorphisms and risk of coronary heart disease in a Han population in East ChinaThe role of triglycerides in atherosclerosis.Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart diseaseRelation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal studyHepatic ABCA1 and VLDL triglyceride production.How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease.Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea.Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteinsApolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoformsThe association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on itEffects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease.Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in HumansReducing vascular events risk in patients with dyslipidaemia: an update for cliniciansApolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutationsLipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities StudyMultiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoringNigerian Honey Ameliorates Hyperglycemia and Dyslipidemia in Alloxan-Induced Diabetic Rats.Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women.
P2860
Q24608464-8EB636B7-DF30-4FEE-9D05-DAF41ECC7794Q26743466-A7A0ED90-DD53-44F1-9403-C26B2C2A87C9Q26864682-02120B4E-BB8D-4EC6-B7FA-937FD8604300Q27968233-BE228951-2861-4A65-AD51-1EFB11EBC18FQ28077776-B8EEB6E2-D284-4F0F-B15F-1472501E5BAEQ30357715-CE8662E5-D000-4612-BE68-A448BFEB59FAQ30408720-E1F99882-7FFE-4385-A15C-6B8BE6F4C288Q30536352-46D3FF5E-FDEA-4C2A-8DD2-088FD35F11B6Q33639909-252B37B5-8D20-4CF0-BCC1-0C00792B5B70Q33717612-A0BF170A-20B7-4389-A9C2-3D053CF2689DQ33858526-C0A3A834-7B55-41C8-8A14-99036C016BC8Q34119914-34D85B9D-F085-461B-9C51-F5A6E9513CAAQ34172178-CF39F045-ECE6-4955-B634-C51BF94124FCQ34238727-2260536C-6397-4879-BC9A-F4ED498EE666Q34410638-491322A0-2BFE-4F00-9CFC-90248B4F37AAQ34955753-3E17C138-BF5B-447E-BCB2-C2DB4B7D6335Q35048354-DF539576-7907-45A3-A148-63E4457D1EB9Q35120360-A1047A32-D333-4B9F-9C30-703449E372C8Q35460381-2E80B932-7183-45B1-918E-C6F1315B7473Q35565455-F36427E3-A723-4F8C-95DA-B04B606C550BQ35602424-7DB61B10-11EC-4D43-A9A7-A3A23A3CA2CAQ35628166-DA4D012D-9B3C-4986-8F19-C9A4FF05BD5AQ35735742-6FCE6164-81A5-414B-84C2-96ABB7993F17Q35737630-5B9F6C09-580E-487F-878D-4275BE8B1DC5Q35738372-D28D99A8-5ADD-495D-AC66-D751F3778C79Q35771163-FE25D100-0B71-47A9-AA74-B213B1DFD0CFQ35830163-4AFE4687-69E3-4929-91A3-352CDB0E35D5Q35839701-A5057E53-9768-4A2B-950B-075FFCB8045BQ35915137-A2E6E8FF-3923-4853-A399-D9C99F05B476Q36072219-CF8B0F16-F135-4110-AD30-B78D0DEF3A23Q36144245-081E9E31-0E9F-42F2-833D-9AB69E35AF3BQ36145257-D9283D9F-9A61-427A-8C25-3AF9DC246185Q36366340-DD8B7B1D-63AB-44D8-9727-AE5876B0E7CFQ36403156-75729E00-028A-4070-AEE4-969110B1BCB3Q36443768-C856B287-4F2E-4E83-9ECD-29D618E61B1CQ36509548-AAB1AA03-1ED7-4269-B23A-298FF28AAC67Q36517373-6EC356E1-01E2-41B4-A555-BC1BEA15539BQ36731728-D689CB7E-6CB8-4E43-AF89-113D48DA0758Q36731956-7A93E612-7B4B-47A9-AFF8-24F017AF938CQ36836003-8F2E28C5-50DB-4F32-878E-249E03DE41C8
P2860
Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Apolipoprotein C-III and the m ...... -density lipoprotein phenotype
@ast
Apolipoprotein C-III and the m ...... -density lipoprotein phenotype
@en
type
label
Apolipoprotein C-III and the m ...... -density lipoprotein phenotype
@ast
Apolipoprotein C-III and the m ...... -density lipoprotein phenotype
@en
prefLabel
Apolipoprotein C-III and the m ...... -density lipoprotein phenotype
@ast
Apolipoprotein C-III and the m ...... -density lipoprotein phenotype
@en
P2093
P2860
P1433
P1476
Apolipoprotein C-III and the m ...... -density lipoprotein phenotype
@en
P2093
Christina Khoo
Chunyu Zheng
Frank M Sacks
Jeremy Furtado
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.875807
P407
P577
2010-04-05T00:00:00Z